Related news from
Mon, 22 Apr 2024 13:00:11 +0000	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Sun, 21 Apr 2024 09:08:00 +0000	These Biotech Stocks Could Soar 120% and 295%, According to Wall Street Catalysts lie ahead for both of these companies.
Fri, 19 Apr 2024 15:02:41 +0000	12 Most Shorted Stocks in 2024 In this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted Stocks in 2024. Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that […]
Mon, 15 Apr 2024 10:00:00 +0000	Shah Capital nominates two highly qualified independent director candidates for Novavax Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management’s failure to capitalize on Novavax’s many significant competitive advantages and TAM opportunities The letter highlights that the underperformance is self-inflicted and is the result of reactive leadership and outd
Mon, 15 Apr 2024 04:44:56 +0000	UPDATE 4-Novavax investor Shah Capital pushes for board shakeup Novavax shareholder Shah Capital is pushing the vaccine maker to add two of its nominees to the board to help tackle "underperformance" at the company and improve its share price. The hedge fund nominated Suresh Katta, founder and CEO of biotech firm Saama, and Venkat Peri, CEO of Quantiva Health, to Novavax's eight-member board, saying the duo had the experience in setting the company's strategic direction.
Sat, 13 Apr 2024 20:22:00 +0000	Better Buy: Bluebird Bio Vs. Novavax Who wins this face-to-face between two beaten-down biotechs?
Fri, 12 Apr 2024 10:35:00 +0000	Down 60% From Its 52-Week High, Is Novavax Stock a Buy? Is there still too much risk surrounding this business?
Thu, 11 Apr 2024 13:12:00 +0000	Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn? To extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple restructuring initiatives that are aimed at lowering operating expenses and enhancing profitability.
Tue, 09 Apr 2024 20:30:00 +0000	Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? The 2024 presidential election is shaping up to be just as exciting and contentious the 2020 contest. That’s because it looks to be a rematch between President Biden and former President Trump. There’s a wildcard thrown in this time with Robert Kennedy Jr. running an independent campaign that could pull voters from both sides. The stock market went on a rollercoaster ride four years ago. A decade-long bull market was brought up short by the pandemic. The S&P 500 lost one-third of its value in a
Wed, 03 Apr 2024 17:18:12 +0000	Ex-Pharma Executive and Cousin Admit to Insider Trading of Kodak (Bloomberg) -- A former Phlow Corp. executive and his cousin admitted to insider trading on confidential information about a pandemic-related government loan to Eastman Kodak Co. Most Read from BloombergKim Jong Un Faces Annihilation in Most Korea War ScenariosApple Explores Home Robotics as Potential ‘Next Big Thing’ After Car FizzlesTSMC Facilities to Resume Production Overnight After QuakeA Million Simulations, One Verdict for US Economy: Debt Danger AheadTrump Media’s Business Doesn’t Matter
Wed, 03 Apr 2024 13:00:11 +0000	Why Investors Need to Take Advantage of These 2 Medical Stocks Now Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Tue, 02 Apr 2024 14:15:00 +0000	1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague These stocks could move in very different directions over the long run.
Mon, 01 Apr 2024 12:00:00 +0000	Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will showcase continued progress on data from its updated COVID-19 vaccine (NVX-CoV2601) and provide an overview of its influenza and COVID-19-Influenza Combination (CIC) vaccine candidates at the World Vaccine Congress 2024 (WVC) in Washington, DC, April 2 to 4, 2024.
Fri, 29 Mar 2024 15:30:29 +0000	Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound? Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wed, 27 Mar 2024 16:24:00 +0000	Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.
Sat, 09 Mar 2024 06:59:00 +0000	1 Beaten-Down Stock That's Still Not Worth Buying For this biotech, a rebound seems far too unlikely.
Thu, 07 Mar 2024 19:52:29 +0000	7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode There’s a simple reason why short-squeeze stocks to buy represent a powerful catalyst: they’re intuitive and easier to engage. Buying something and hoping that it appreciates in value represents an organically sensible strategy. It’s the reason why people collect everything from baseball cards to luxury Swiss watches. Stated differently, it doesn’t take much to explain the rationale behind short-squeeze stocks to buy. On the other hand, shorting a stock represents an incredibly complex affair by
Thu, 07 Mar 2024 10:28:00 +0000	Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street Could these biotech companies still win in the vaccine market and beyond?
Wed, 06 Mar 2024 22:13:29 +0000	The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar Big GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) may have lost investor focus, but these meme stocks keep interests high. Of the many indicators aiding to time the market, short interest remains the most popular. Shorting stocks, especially meme stocks, means that traders expect profits from borrowing, selling, and repurchasing them later at a discount. The percentage of float shorted gives traders a clue as to how many shares are in that transitory stage before repurchasing when they ha
Tue, 05 Mar 2024 18:05:07 +0000	It’s Time! 3 Failing Biotech Stocks to Sell Right Now Healthcare stocks, especially biotech companies, are very risky for investors. Their share price can be highly volatile and surge higher or plummet lower based on news regarding a clinical trial, treatment authorization, or any number of events that could be or break a company. In other industries, this massive shift in price action isn’t nearly as prevalent. Some biotech companies are failing and won’t offer investors much in the way of returns. And they should be ditched from any watchlist bec